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Abstract
Background: Mycobacterium tuberculosis has a global population structure consisting of six main phylogenetic lineages
associated with specific geographic regions and human populations. One particular M. tuberculosis genotype known as
‘‘Beijing’’ has repeatedly been associated with drug resistance and has been emerging in some parts of the world. ‘‘Beijing’’
strains are traditionally defined based on a characteristic spoligotyping pattern. We used three alternative genotyping
techniques to revisit the phylogenetic classification of M. tuberculosis complex (MTBC) strains exhibiting the typical ‘‘Beijing’’
spoligotyping pattern.
Methods and Findings: MTBC strains were obtained from an ongoing molecular epidemiological study in Switzerland and
Nepal. MTBC genotyping was performed based on SNPs, genomic deletions, and 24-loci MIRU-VNTR. We identified three
MTBC strains from patients originating from Tibet, Portugal and Nepal which exhibited a spoligotyping patterns identical to
the classical Beijing signature. However, based on three alternative molecular markers, these strains were assigned to
Lineage 3 (also known as Delhi/CAS) rather than to Lineage 2 (also known as East-Asian lineage). Sequencing of the RD207
in one of these strains showed that the deletion responsible for this ‘‘Pseudo-Beijing’’ spoligotype was about 1,000 base
pairs smaller than the usual deletion of RD207 in classical ‘‘Beijing’’ strains, which is consistent with an evolutionarily
independent deletion event in the direct repeat (DR) region of MTBC.
Conclusions: We provide an example of convergent evolution in the DR locus of MTBC, and highlight the limitation of using
spoligotypes for strain classification. Our results indicate that a proportion of ‘‘Beijing’’ strains may have been misclassified in
the past. Markers that are more phylogenetically robust should be used when exploring strain-specific differences in
experimental or clinical phenotypes.
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Introduction
Mycobacterium tuberculosis complex (MTBC) adapted to humans
consist of six main phylogeographical lineages [1]. There is
increasing evidence that strain diversity in MTBC plays a role in
the outcome of infection and disease in tuberculosis (TB) [2,3].
One particular MTBC genotype known as ‘‘Beijing’’ has
repeatedly been associated with drug resistance [4] and increased
virulence in animal models [2]. This genotype was first described
in 1995 [5], and has traditionally been defined based on a
characteristic spoligotyping pattern [6]. More recently, phyloge-
netic analyses showed that the Beijing strain family belongs to
Lineage 2 (known as East Asian lineage), which is one of the six
main human-adapted lineages of MTBC [7,8]. Beijing strains are
most often isolated in East- and Southeast Asia, in countries of the
former Soviet Union, and have recently been emerging in South
Africa [1,6,9,10].
Spoligotyping is based on the Clustered Regulatory Short
Palindromic Repeats (CRISPR) region known as the Direct
Repeat (DR) locus in MTBC. This region is characterized by
series of direct repeats interspersed by short unique regions called
‘‘spacers’’ [11]. The characteristic spoligotyping pattern of Beijing
strains reflects the loss of the first 34 spacers of a total of 43 used in
standard spoligotyping [5,10]. Repetitive DNA sequences like the
DR locus exhibit a high rate of change, and convergent evolution
can lead to identical genetic character states in phylogenetically
unrelated strains; a phenomenon referred to as homoplasy [8].
We recently identified novel SNP markers that define the main
phylogenetic lineages [8,12]. In contrast to spoligotyping, SNPs in
MTBC exhibit almost no homoplasy [8]. Here we used these
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SNPs, combined with genomic deletion and MIRU-VNTR
analyses to revisit the phylogenetic classification of MTBC strains
exhibiting the classical ‘‘Beijing’’ spoligotyping pattern.
Methods
MTBC isolates were obtained during an ongoing population-
based study on the molecular epidemiology of TB in Switzerland,
and from an ongoing hospital-based study in Kathmandu, Nepal.
Mycobacterial isolates were cultured and DNA extracted
according to standard laboratory procedures. Spoligotyping was
performed as previously described and compared to data
published in SpolDB4 [13,14]. 24-loci MIRU-VNTR was
performed as previously described [11], and the data analyzed
using the MIRU-VNTRplus online tool (http://www.miru-
vntrplus.org). Determination of the main phylogenetic MTBC
lineages was performed by TaqMan real-time PCR (Taqman,
Applied Biosystems, USA) using primers (Sigma-Aldrich, Buchs,
Switzerland), Taqman Universal MasterMix II and Taqman
minor groove binder probes (Table 1) targeting lineage-specific
SNPs reported previously [8,12]. Region of difference (RD)
deletion PCRs were performed for RD105, RD207 and RD750
[15]. PCR products of RD207 were directly sequenced. All
genotyping experiments of the three ‘‘Pseudo-Beijing’’ isolates
described here were repeated at least twice by two independent
investigators.
The Swiss study was approved by the ethics committee of the
Canton of Berne, Switzerland. Written informed consent was
obtained from the patient by the treating physicians. In some cases
informed consent could not be obtained because the patient could
not be located or was known to have died. For these cases we
obtained permission from the Federal expert commission on
confidentiality in medical research (based at the Federal Office of
Public Health, Bern, Switzerland) to use the data provided by the
treating physician based on clinical notes. The study in Nepal was
approved by the Nepal Health Research Council (NHRC),
Kathmandu, Nepal, and the ethics committee of the Canton of
Basel, Switzerland. Written informed consent was obtained for all
Nepalese patients.
Results
Among the isolates recovered in Switzerland, we identified a
total of 52 that exhibited the characteristic ‘‘Beijing’’ spoligotype.
SNP-genotyping confirmed that 50 of these (96.2%) belonged to
Lineage 2. Two isolates (3.8%) belonged to Lineage 3 (also known
as Delhi/CAS). Similarly, among 55 Nepalese isolates with a
Beijing spoligotype, 54 (98.2%) were confirmed as belonging to
Lineage 2, while one isolate (1.8%) belonged to Lineage 3
(Table 2). The three Lineage 3 isolates were epidemiologically
Table 1. Sequence information of probes and primers used in this study to detect main phylogenetic lineages of Mycobacterium
tuberculosis complex isolates by single nucleotide polymorphisms genotyping.
Lineage Alternative name SNP name* Primer sequences Probe sequences
2 East Asian Lineage Rv2952_0526n F: 59-CCTTCGATGTTGTGCTCAATGT-39 Wild type probe:
FAM: 59-CCCAGGAGGGTAC-39
R: 59-CATGCGGCGATCTCATTGT-39 Lineage-specific probe:
VIC: 59-CCCAGGAAGGTACT-39
3 Delhi/CAS Rv3804c_0012s F: 59-GCATGGATGCGTTGAGATGA-39 Lineage-specific probe:
FAM: 59-AAGAATGCAGCTTGTCGA-39
R: 59-CGAGTCGACGCGACATACC-39 Wild-type probe:
VIC: 59-AAGAATGCAGCTTGTTGA-39
*as reported in Ref. [8].
F: forward; R: reverse; SNP, single nucleotide polymorphisms.
Probes are minor groove binder probes.
doi:10.1371/journal.pone.0024737.t001
Table 2. Spoligotyping, single nucleotide polymorphism (SNP) and region of difference (RD) PCR results from the three
Mycobacterium tuberculosis isolates belonging to Lineage 3.
Specimen no.
Spoligotyping pattern
(spacers 1–43) SIT1 Clade SNP for Lineage 2
SNP for
Lineage 3
Deletion of
RD 105
Deletion of
RD 750
1395 %%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%
%%%%&&&&&&&&&
1 Beijing 2 + 2 +
1476 %%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%
%%%%&&&&&&&&&
1 Beijing 2 + 2 +
2503 %%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%
%%%%&&&&&&&&&
1 Beijing 2 + 2 +
1Spoligotype International Type (SIT) according to the definition in SpolDB4 database using SITVIT2 (http://www.pasteur-guadeloupe.fr:8081/SITVITDemo/index.jsp).
+, present; 2, absent; RD, region of difference; SNP, single nucleotide polymorphism.
doi:10.1371/journal.pone.0024737.t002
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unrelated and were isolated from HIV-negative patients. The two
strains from Switzerland were isolated in patients living in
Switzerland but originating from Portugal and Tibet, and the
strain from Nepal was isolated in a patient born and living in
Nepal. All but one strains were pan-susceptible (one isolate with a
katG S315T mutation). We found no evidence for a mixed-strain
infection or clonal heterogeneity [16] based on the 24-loci MIRU-
VNTR pattern.
To confirm our SNP data, we subjected these three isolates to
further molecular investigations. Lineage 2 strains, including all
Beijing strains, are deleted in RD105 [7,10], whereas Lineage 3
strains have a deletion in RD750 [7]. We found that the three
strains of interest had RD105 intact and a deletion in RD750
(Table 1). In addition, the MIRU-VNTR profiles of these isolates
clustered with the Lineage 3 strains (Delhi/CAS) rather than with
the Beijing strains (Figure 1). The further investigations thus
confirmed that these three strains belonged to Lineage 3 rather
than Lineage 2.
We explored the molecular mechanism by which these Lineage
3 isolates acquired their ‘‘Pseudo-Beijing’’ spoligotyping patterns.
‘‘True’’ Beijing strains harbor a 7,399 base pair (bp) deletion in
RD207, which is responsible for the missing spacers 1–34 [10]. We
thus hypothesized that the strains of interest might have acquired a
similar but distinct deletion linked to an independent mutational
event. We amplified RD207 [15] but failed to obtain a product in
two of the three strains. Strain 1395 for which our PCR was
successful yielded a PCR product that was about 1,000 bp larger
than the corresponding product seen in true Beijing strains
(Figure 2), indicating that the deletion responsible of the ‘‘Pseudo-
Beijing’’ spoligotype in 1395 was about 1000 bp smaller than the
classical deletion of RD207. Direct sequencing of the PCR
product showed that the 39-deletion boundary was 1,093 bp
upstream (GenBank accession no. JF789456) of the deletion end
point for RD207 published previously [15]. These results again
indicate that the deletion in strain 1395 is distinct from the
standard RD207 deletion. We were unable to determine the exact
deletion starting point of this new deletion due to the repetitive
nature of the DR region.
Discussion
In this report we present three cases with MTBC isolates
harboring spoligotype patterns identical to the Beijing signature,
which were assigned to Lineage 3 (also known as Delhi/CAS)
rather than to Lineage 2 (also known as East-Asian) based on three
alternative molecular markers. We also provide evidence that
these strains acquired independent deletion(s) in the DR locus of
MTBC.
The fact that phylogenetically unrelated MTBC strains can
harbor identical or very similar spoligotyping patterns has been
observed before [17,18]. The DR locus of MTBC is highly
variable, and convergent evolution can lead to homoplasy in
spoligotyping patterns [8]. Even though strain classification based
on spoligotyping will assign MTBC strains to the correct
phylogenetic lineages in about 90% of the cases, some strains
cannot be classified at all [19], and others will be misclassified as
shown here.
Misclassification of ‘‘Beijing’’ strains is particularly relevant
given that this strain family has received increased attention over
the last few years [6]. In addition to their association with clinical
drug resistance and hyper-virulence in animal models [2,4],
Figure 1. Neighbor-joining dendogram based on the copy numbers of 24 MIRU-VNTR loci using the web-basedMIRU-VNTRplus tool
(http://mvpl.mlvaplus.net). The Mycobacterium tuberculosis isolates reported here are highlighted in boxes, reference strains are from the MIRU-
VNTRplus database. The corresponding spoligotyping patterns are shown as a reference but were not included in the construction of the dendogram.
doi:10.1371/journal.pone.0024737.g001
Figure 2. Results of Region of Difference (RD) 207 polymerase
chain reaction. M, molecular weight marker; 1, ‘‘True’’ Beijing isolate;
2, ‘‘Pseudo-Beijing’’ isolate no. 1395; 3, Negative control.
doi:10.1371/journal.pone.0024737.g002
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Beijing strains have been emerging in Cape Town, South Africa
[9,20], and the Canary islands [21].
The data presented here suggest that a small fraction of strains
traditionally referred to as ‘‘Beijing’’ strains might belong to
another phylogenetic lineage. We stress that the prevalence of this
phenomenon observed in our study of isolates from Switzerland
and Nepal will not reflect the global M. tuberculosis genetic diversity.
Of note, the three ‘‘Pseudo-Beijing’’ strains belonging to Lineage 3
were isolated from patients originating from three different
countries. Given the mutational dynamics within the DR locus,
and the fact that strains harboring the classical Beijing spoligotyp-
ing pattern are rarely verified using independent molecular
markers, it is possible that other so-called ‘‘Pseudo-Beijing’’ strains
might turn out to belong to yet a different MTBC lineage. Further
studies are needed to better define the global molecular
epidemiology of these strains, including clinical phenotypes.
In conclusion, our case report illustrates an example of
convergent evolution in the DR locus of MTBC, and highlights
the limitation of using spoligotypes for genotypic classification.
Markers that are more phylogenetically robust should be used
when looking for associations between particular MTBC geno-
types and experimental or epidemiological variables [2]. Future
work should define the global prevalence and phenotypic
characteristics of the ‘‘Pseudo-Beijing’’ strains.
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